-
Founded in:
2006-04-06 -
Country:
China -
Address:
No. 198, Huacheng Road, Jintan District, Changzhou -
Tax NO.:
91320413786327805B -
Registered Funds:
30 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 2-Cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-α]isoquinolin-4-one |
It is effective against schistosoma, tapeworm, cysticercosis, Clonorchis sinensis, Paragonimus thoracis, and Paniculatus. It has two main pharmacological effects on the worm: 1. The muscles of the worm undergo tonic contraction and produce spastic paralysis; 2. The cortex of the worm is damaged and the host immune function is involved. In addition, it can also cause secondary changes, depolarizing the surface membrane of the worm, significantly reducing the activity of cortical alkaline phosphatase, inhibiting glucose uptake, depleting endogenous glycogen, and inhibiting the synthesis of nucleic acid and protein in the worm.
More
It is effective against schistosoma, tapeworm, cysticercosis, Clonorchis sinensis, Paragonimus thoracis, and Paniculatus. It has two main pharmacological effects on the worm: 1. The muscles of the worm undergo tonic contraction and produce spastic paralysis; 2. The cortex of the worm is damaged and the host immune function is involved. In addition, it can also cause secondary changes, depolarizing the surface membrane of the worm, significantly reducing the activity of cortical alkaline phosphatase, inhibiting glucose uptake, depleting endogenous glycogen, and inhibiting the synthesis of nucleic acid and protein in the worm. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nateglinide |
Nateglinide is an amino acid derivative and an oral antidiabetic drug used to treat patients with type 2 diabetes. The action of nateglinide depends on the function of pancreatic beta cells. Nateglinide binds to the ATP-sensitive K channel receptor on the beta cell membrane and closes it, causing cell depolarization, calcium channel opening, calcium influx, stimulating insulin secretion, and lowering blood sugar. The insulin secretion-promoting effect of nateglinide depends on the glucose level. When the glucose level is low, the insulin secretion is weakened. Nateglinide has a high degree of tissue selectivity and has a low affinity for cardiac muscle and skeletal muscle.
More
Nateglinide is an amino acid derivative and an oral antidiabetic drug used to treat patients with type 2 diabetes. The action of nateglinide depends on the function of pancreatic beta cells. Nateglinide binds to the ATP-sensitive K channel receptor on the beta cell membrane and closes it, causing cell depolarization, calcium channel opening, calcium influx, stimulating insulin secretion, and lowering blood sugar. The insulin secretion-promoting effect of nateglinide depends on the glucose level. When the glucose level is low, the insulin secretion is weakened. Nateglinide has a high degree of tissue selectivity and has a low affinity for cardiac muscle and skeletal muscle. |
105816-04-4 | 24 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acetaminophen |
It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects
More
It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects |
120mg | 103-90-2 | 68 |
| Chlorphenamine maleate |
It is an antihistamine that can relieve symptoms such as runny nose, nasal congestion, and sneezing.
More
It is an antihistamine that can relieve symptoms such as runny nose, nasal congestion, and sneezing. |
0.5mg | 113-92-8 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Chlorprothixene |
It can improve mental disorders by blocking postsynaptic dopamine receptors in the brain, inhibit the ascending activation system of the brainstem reticular formation, cause sedation, and inhibit the medulla chemoreceptor area to exert an antiemetic effect. This product has weak anti-adrenergic and anti-cholinergic effects, and has anti-depressant and anti-anxiety effects.
More
It can improve mental disorders by blocking postsynaptic dopamine receptors in the brain, inhibit the ascending activation system of the brainstem reticular formation, cause sedation, and inhibit the medulla chemoreceptor area to exert an antiemetic effect. This product has weak anti-adrenergic and anti-cholinergic effects, and has anti-depressant and anti-anxiety effects. |
113-59-7 | 1 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefadroxil |
The first generation of oral cephalosporin has good antibacterial effect on most strains of penicillinase-producing and non-penicillinase-producing Staphylococcus aureus, coagulase-negative Staphylococcus, Streptococcus pneumoniae, group A hemolytic Streptococcus, etc. It also has certain antibacterial activity against Escherichia coli, Proteus mirabilis, Salmonella, Shigella, Haemophilus influenzae and gonococci. Methicillin-resistant Staphylococcus, Enterococcus, indole-positive Proteus, Enterobacter, Serratia and other Enterobacteriaceae, Pseudomonas aeruginosa and Bacteroides fragilis are resistant to this product.
More
The first generation of oral cephalosporin has good antibacterial effect on most strains of penicillinase-producing and non-penicillinase-producing Staphylococcus aureus, coagulase-negative Staphylococcus, Streptococcus pneumoniae, group A hemolytic Streptococcus, etc. It also has certain antibacterial activity against Escherichia coli, Proteus mirabilis, Salmonella, Shigella, Haemophilus influenzae and gonococci. Methicillin-resistant Staphylococcus, Enterococcus, indole-positive Proteus, Enterobacter, Serratia and other Enterobacteriaceae, Pseudomonas aeruginosa and Bacteroides fragilis are resistant to this product. |
66592-87-8 | 28 |